1. Home
  2. SHOE vs LAB Comparison

SHOE vs LAB Comparison

Compare SHOE & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHOE

Shoe Station Group Inc. Common Stock

N/A

Current Price

$14.87

Market Cap

433.9M

ML Signal

N/A

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.89

Market Cap

347.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOE
LAB
Founded
N/A
1999
Country
United States
United States
Employees
5000
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
433.9M
347.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
SHOE
LAB
Price
$14.87
$0.89
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.35
AVG Volume (30 Days)
604.8K
6.3M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.54
EPS
N/A
0.33
Revenue
N/A
$101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.63
P/E Ratio
N/A
$2.77
Revenue Growth
N/A
N/A
52 Week Low
$14.79
$0.70
52 Week High
$16.29
$1.72

Technical Indicators

Market Signals
Indicator
SHOE
LAB
Relative Strength Index (RSI) 36.23 50.21
Support Level N/A $0.79
Resistance Level $16.20 $1.02
Average True Range (ATR) 0.64 0.07
MACD -0.10 0.01
Stochastic Oscillator 6.83 77.22

Price Performance

Historical Comparison
SHOE
LAB

About SHOE Shoe Station Group Inc. Common Stock

Shoe Station Group Inc is a one-stop family footwear destination that offers an impressive selection from top brands. It is a fashion destination for footwear, southern-inspired accessories, and apparel. The group has physical stores throughout five Southern states and is available online at ShoeStation.com, shipping all across the U.S. Its offer products for Women's, Men's, and Kids.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: